The Report

Deep dives into company funding, growth strategies, and market insights from the world's most innovative businesses

7 reports and counting

Updated daily with latest market intelligence
Fundraising
Genentech

Genentech Raises $60B in Public

Genentech, a Biotech company based in 1 DNA Way, South San Francisco, CA 94080, has raised $60B in Public at a $65B valuation led by Roche.

Fundraising News Team
Jan 1, 2024
2 min read
Biotech
Genentech

Genentech raises $60B Public at $65B valuation

Genentech raises $60B in Public at $65B valuation. Biotechnology company...

Editorial Team
Jan 1, 2024
1 min read$60B
Biotechnology
Genentech

Genentech Headquarters - Office Location & Address

Discover Genentech's headquarters at 1 DNA Way, South San Francisco, CA 94080. Biotechnology and drug development. Learn about the office facilities and work environment.

Editorial Team
Oct 5, 2025
2 min read
Venture Capital
Mayfield Fund

Mayfield Fund Headquarters - Office Location & Address

Discover Mayfield Fund's headquarters at 2800 Sand Hill Rd, Menlo Park, CA 94025. Venture capital firm investing in early-stage enterprise technology and consumer companies. 50+ year history backing companies including Amgen, Genentech, Compaq, and Marketo.

Editorial Team
Oct 6, 2025
2 min read
Biotech
BioAge Therapeutics

BioAge Therapeutics Raises $350M Series C to Transform Healthcare

BioAge Therapeutics secures $350M in Series C funding at $4.3B valuation to advance anti-aging drug trials, expand research into age-related diseases, and scale manufacturing for clinical studies.

Editorial Team
Sep 28, 2025
1 min read$350M
Pharmaceuticals
BioPharmaceuticals Next

BioPharmaceuticals Next Secures $1.6B Series E to Lead Pharmaceuticals Innovation

BioPharmaceuticals Next raises $1.6B in Series E funding at $24.3B valuation to advance 12 drug candidates through clinical trials, scale gene therapy manufacturing, and expand personalized medicine programs.

Editorial Team
Sep 20, 2025
2 min read$1.6B
Gene Therapy
GeneEdit Therapeutics

GeneEdit Therapeutics Raises $2.0B Series F for Revolutionary Gene Therapy Technology

GeneEdit Therapeutics secures $2.0B in Series F funding at $29.5B valuation to pioneer breakthrough gene therapy technology.

Editorial Team
Sep 15, 2025
2 min read$2.0B
Page 1

Showing 7 reports • Page 1 • Category: all

Stay ahead of the market

Get weekly insights delivered to your inbox. No spam, just intelligence.